| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f644c38d973de06ddce2c36265f0439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a8231c53da836ba180c9e6da504e406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a87fc3648eb840b7aac6688975075c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffce2ba8975a33f9ef8cc755a31847d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd7e2f80b2aa5557195e270a39b8b7ed |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243 |
| filingDate |
2006-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_919172ca5c02f55b9bfeb45b93f9d9c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2abc9f93808964df6ced4f4da93cd1a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e83596ea4142abe05882bc59b13607c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ffd5e9d3199edcb26440a97c962002e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19b975293a601c5675167de76660462a |
| publicationDate |
2007-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007190182-A1 |
| titleOfInvention |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally |
| abstract |
One aspect of the invention relates to methods of treating cancer in a patient comprising administering intraperitoneally to a patient in need thereof a cancer treating effective amount of a lipid-based platinum compound formulation wherein the concentration of the platinum compound of the lipid-based platinum compound formulation is greater than about 1.2 mg/ml. Another aspect of the invention relates to lipid-based platinum compound formulations where the concentration of the platinum compound is greater than about 1.2 mg/ml. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009197854-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019307690-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9107824-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113453667-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010310661-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010260832-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011033528-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011052581-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010178328-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8168661-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11291644-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009275549-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004053882-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8178564-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8173686-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8168662-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020093044-A1 |
| priorityDate |
2005-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |